Filing Details
- Accession Number:
- 0000950170-24-115348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-17 16:45:35
- Reporting Period:
- 2024-10-15
- Accepted Time:
- 2024-10-17 16:45:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1861560 | Nuvalent Inc. | NUVL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1862900 | Richard James Porter | C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-10-15 | 27,000 | $27.85 | 215,113 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-10-15 | 26,186 | $102.26 | 188,927 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-10-15 | 814 | $103.01 | 188,113 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (Right to Buy) | Disposition | 2024-10-15 | 27,000 | $0.00 | 27,000 | $27.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 393,780 | 2033-01-06 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 2, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.76 to $102.70, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.80 to $103.43, inclusive.
- The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Billionaire Hedge Funds
